Aernoud Fiolet

165 Reply. Colchicine in Patients with Chronic Coronary Disease REFERENCES 1. Tardif J-C, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019;381:2497-2505. 2. Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics — 2020 update: a report from the American Heart Association. Circulation 2020;141(9):e139-e596. 3. NIH policy on sex as a biological variable. NIH Office of Research on Women’s Health, 2020 (https://orwh.od.nih.gov/sex-gender/nih-policy-sex-biological-variable. ). 4. Evaluation of gender differences in clinical investigations: guidance for institutional reviewboards and clinical investigators. Rockville, MD: Food and Drug Administration, January 1998 (https:// www.fda.gov/regulatory-information/search-fda-guidance-documents/evaluation-gender- differences-clinical-investigations). 5. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. International Committee of Medical Journal Editors, 2019 (http://www.icmje. org/icmje-recommendations.pdf ).